ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Cash on Hand 2017–2025
ImmuCell Corporation annual/quarterly cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- ImmuCell Corporation cash on hand for the quarter ending December 31, 2025 were 3.8M, a 1.29% increase year-over-year.
- ImmuCell Corporation cash on hand for 2025 were 3.8M, a 1.29% increase from 2024.
- ImmuCell Corporation cash on hand for 2024 were 3.8M, a 283.99% increase from 2023.
- ImmuCell Corporation cash on hand for 2023 were 978,741, a 83.10% decrease from 2022.
- ImmuCell Corporation cash on hand for 2022 were 5.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| ImmuCell Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $4 |
| 2023 | $1 |
| 2022 | $6 |
| 2021 | $10 |
| 2020 | $7 |
| 2019 | $6 |
| 2018 | $3 |
| 2017 | $4 |
| ImmuCell Corporation Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $4 |
| 2024-12-31 | $4 |
| 2023-12-31 | $1 |
| 2022-12-31 | $6 |
| 2021-12-31 | $10 |
| 2020-12-31 | $7 |
| 2019-12-31 | $6 |
| 2018-12-31 | $3 |
| 2017-12-31 | $4 |
ImmuCell Corporation Cash on Hand — FAQ
ImmuCell Corporation (ICCC) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's cash on hand history?
The chart and table above show ImmuCell Corporation's cash on hand by year and by quarter, including the growth rate.